Researchers develop robotic intracellular sensing system
An automated intracellular sensing system could provide an efficient approach to reveal the cellular characteristics of disease progression.
List view / Grid view
An automated intracellular sensing system could provide an efficient approach to reveal the cellular characteristics of disease progression.
In a petri dish under an environmental condition reminiscent of ALS, the team found that the protein activates a unique pathway inside cells that increases survival and protects endothelial cells from toxic substances in the blood.
This whitepaper reviews the drug discovery progress for neurodegenerative diseases, focusing on promising candidates identified using iPSC technology.
The best protection from COVID-19 will come from intranasally-delivered vaccines, due to the effectiveness of mucosal IgA antibodies, say researchers from the University at Buffalo.
UCLA-led team discovers that using early-stage stem cells is a key to producing structures that are reliable models of disease.
Discover why the Hyperion+ Imaging System is the standard to assess tumour-immune interactions and get deep single-cell insights.
Discover all the ways you can harness ultrasensitive immunoassays to stay at the forefront of neuroscience research.
Compendium of iQue® advanced flow cytometry platform application posters: Antibody discovery and immuno-oncology.
Researchers have developed a new method that enables high-throughput screening of Huntington’s disease organoids.
Alzheimer’s disease remains one of the largest challenges for the global ageing population. In this article, Victoria Rees, Editor of Drug Target Review, reviews some of the latest research, highlighting how progress has been made in understanding tau as well as how to potentially target this protein as a therapeutic strategy against…
Learn how R&D Systems™ Avi-tag biotinylated proteins can be used as an alternative to amine biotin coupling in surface plasmon resonance experiments.
Researchers have successfully characterised a part of the brain that shows the earliest accumulation of tau protein, an important biomarker for the development of Alzheimer's disease.
Scientists at UTHealth Houston have developed an agonistic antibody that reduced the amyloid pathology in mice with Alzheimer’s disease.
The new labelling system includes a variant of ascorbate peroxidase which is fused to another protein that is known to seek out exosomes.
Trust in your results — Experience the benefits of iQue® advanced flow cytometry.